Dergiler / The European Research Journal / 2020 / Cilt: 6 - Sayı: 5

Investigation of the relationship between atherosclerosis and interleukin-6 -174G ⁄ C gene polymorphism

Sayfa
422–428
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, broad-based studies should be carried out considering suitable conditions andmulti-factor features.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Atherosclerosis is a chronic disease that causes various cardiovascular complications.
📊
Temel Bulgular & Veri:Interleukin-6 (IL-6) plays an important role in the regulationof proinflammation.
💡
Sonuç & Katkı:Therefore, broad-based studies should be carried out considering suitable conditions andmulti-factor features.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Atherosclerosis is a chronic disease that causes various cardiovascular complications. The onsetand progression of atherosclerosis depends primarily on genetic factors and life style, but the underlying cellular and molecular mechanisms are still unclear. In recent studies, circulating cytokines have been shown toplay an important role in inflammatory events. Interleukin-6 (IL-6) plays an important role in the regulationof proinflammation. In this study, a single nucleotide polymorphism of IL-6 gene at position -174 was studied.Our aim was to investigate the relationship between IL-6 -174G/C polymorphism and atherosclerosis.Methods: In this prospective randomized study, 104 patients were included in both groups. We used Polymerase Chain Reaction-Restriction Fragment Lenght Polymorphism (PCR-RFLP) method to amplify thepolymorphism region.Results: Allele frequency distributions of IL-6 -174G/C polymorphism in the study and control groups wereevaluated. There were no statistically significant diversity between A and B allele frequencies.Conclusions: The allele frequency and genotype distribution between the groups was not statistically different,which indicates another mechanisms on regulation of these cytokines. Single gene polymorphisms are generallynot reproducible. Therefore, broad-based studies should be carried out considering suitable conditions andmulti-factor features.

🔖

Bu Makaleye Atıf Yap

SANRI, U. S. (2020). Investigation of the relationship between atherosclerosis and interleukin-6 -174G ⁄ C gene polymorphism. The European Research Journal, Cilt: 6 - Sayı: 5, 422–428. https://ajindex.com/articles/360962

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43
  2. Resncik HE, Howard EV. Diabetes and cardiovascular disease. Annu Rev Med 2002;53:245-67
  3. Ridker PM. Clinical application of CRP for cardiovascular disease detection and prevention. Circulation 2003;107:363-9
  4. Christopher KG, Joseph LW. Atherosclerosis: the road ahead. Cell 2001;104:503-16
  5. Borish L, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003;111:460-75
  6. Heinrich PC, Behrmann I, Haan S, Hermanns HM, MüllerNewen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374(Pt 1):1-20
  7. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006;8 Suppl 2:S2
  8. Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE. The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry 2006;77:915-7
  9. Vakili H, Ghaderian SMH, Najar RA, Panah AST, Azargashb E. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron Artery Dis 2011;22:299- 305
  10. Ma Y, Tang RK, Yang X, Peng GG, Liu Y, Wang XM, et al. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, - 572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum Immunol 2011;72:641-51
  11. Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006;17:863-70
  12. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory manual. 2nd ed. N.Y., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, 1989: p. 1659
  13. Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol 2017;13:368-80
  14. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996;97:2130-8
  15. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1- 10
  16. Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC. Inflammatory cytokines in atherosclerosis: current therapeutic approaches, Eur Heart J 2016;37:1723-32
  17. Harismendy O, Notani D, Song X, Rahim RG, Tanasa B, Heintzman N, et al. 9p21 DNA variants associatedwith coronary arterydisease impair interferon-gammasignalling response. N